Whalegun
Home

Neurocrine Biosciences NBIX spent $780K on lobbying in Q1 2023 · Health Issues, Budget and 2 more issues

Trade details

Type
Lobbying report
Amount
$780,000
Quarter
Q1 2023
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
23/04/20

Up 11.4% from last quarter

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Neurocrine Biosciences's other lobbying reports